# Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.

> **NCT00245297** · PHASE2 · COMPLETED · sponsor: **Recoly N.V.** · enrollment: 16 (actual)

## Conditions studied

- Haemophilia A

## Interventions

- **DRUG:** Kogenate FS, reconstituted in a suspension of liposomes

## Key facts

- **NCT ID:** NCT00245297
- **Lead sponsor:** Recoly N.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2007-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00245297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00245297, "Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00245297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*